Tag: Anticoagulants
ASH Suggests Not Using Outpatient Thromboprophylaxis for COVID-19
For discharged patients without suspected or confirmed VTE or other indication for anticoagulation, panel suggests not using anticoagulants
Prophylactic Anticoagulation Aids Hospitalized COVID-19 Patients
Prophylactic-dose anticoagulation, but not treatment-dose anticoagulation, associated with lower 60-day mortality
Guidance Issued for Managing CVST After COVID-19 Vaccination
CVST with thrombocytopenia reported after COVID-19 vaccine with adenoviral vector; management similar to heparin-induced thrombocytopenia
Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
Among patients with a-fib and/or VTE, about one-third received ASA in addition to a DOAC with no clear indication for ASA
Prophylactic Anticoagulation May Cut COVID-19 Mortality
Lower 30-day mortality, no increase in serious bleeding events seen among COVID-19 inpatients receiving early prophylactic anticoagulation
Early Anticoagulation May Not Up Survival in Severe COVID-19
Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients
Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
Interim results show improvement in primary end point of need for ventilation, other organ-supportive interventions
Anticoagulants Not Tied to Higher Risk for GI Bleed in COVID-19
3 percent of hospitalized COVID-19 patients experience gastrointestinal bleeding
Ongoing Anticoagulant Use Does Not Avert Severe COVID-19
No reduction seen in risks for hospital admission, intensive care unit admission, or death due to COVID
High-Dose Anticoagulation May Not Aid COVID-19 Patients
No significant benefit seen for high-dose versus standard anticoagulation therapies, may be harmful
